PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Baking Time Club sells baking supplies through a subscription service and direct to consumers by utilising their own website, Amazon and Etsy. Their aim is to provide customers with unusual and exiting items for the kitchen.
days to go:
Expired
investment:
£64,940
Erpingham House is the UK’s largest vegan restaurant whose aim is to make plant-based dining into the mainstream and provide delicious, healthy food and drinks to people. The company has earned nationwide recognition and, it has been listed in The Times top 20 vegetarian restaurants. It has also been featured in The Guardian and on channel 4’s “what Britain bought.” EH has served over 12,000 customers in its first year and, it has risen to over 20,000 followers on Instagram. The funds will be used to expand the brand & open a second site in Brighton.
days to go:
Expired
investment:
£192,280
Positivitea is a range of teas based on the chakras. They are already stocked in over 80 locations throughout the UK and Europe including Urban Outfitters and Fenwick. The use of the proceeds raised will go towards expanding the team and getting Positivitea in more retail outlets and being used by more suppliers.
days to go:
Expired
investment:
£103,640
TeaTime deliver fresh and healthy tea blends straight to your door. Simply choose how often you wish to receive your box, weekly or fortnightly and TeaTime will dispatch a selection of 4 of their blends out to you within 48 hours.
days to go:
Expired
investment:
£18,940
Just Add Wine is an easy way for home cooks to add the taste of red wine to their recipes without having to open a new bottle or go out and purchase a bottle. Just Add Wine comes concentrated in a small sachet and is the equivalent of adding a full glass to your dish.
days to go:
Expired
investment:
£119,970
BrewBroker are an online marketplace, enabling anyone to buy and sell brewing services. They aim to become the world's biggest brewer, making beer production smarter and more profitable, all without owning their own brewery. They will be using the funding for continued development and launch on the platform.
days to go:
Expired
investment:
£380,990
Doodle Drinks (DD) aims to make all-natural soft drinks that kids can enjoy. The company cites research data arguing that children aged 18 months to 18 years are drinking 26% fewer sugary drinks and consumption for 10-year olds has fallen 35%. It wants to capture this sentiment and deliver a soft drink that's a healthy choice for both parents and their kids. DD has secured distribution with the noted distributor, Bravura Foods. It has also signed a partnership with the largest independent bottler of beverages in Europe and North America, Refresco, who have over 60 manufacturing sites globally to fulfil its objective. DD will use the investment to grow its business, execute its marketing strategy and increase its product range.
days to go:
Expired
investment:
£877,830
